Exelixis, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EXEL Nasdaq 2830 www.exelixis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Exelixis, Inc.

TD Cowen Sees Pipeline Growth Opportunities Supporting Exelixis, Inc. (EXEL) Outlook - May 11th, 2026 2:01 pm
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May - May 7th, 2026 2:05 pm
Why Exelixis (EXEL) Is Up 9.0% After Strong Q1 2026 Earnings And New Buyback Program - May 7th, 2026 6:14 am
Exelixis Seen Trading Steady on Modest Drug Growth, RBC Says - May 6th, 2026 11:41 am
EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus - May 6th, 2026 9:59 am
Exelixis, Inc. Q1 2026 Earnings Call Summary - May 5th, 2026 6:17 pm
Exelixis Q1 Earnings Call Highlights - May 5th, 2026 5:43 pm
Exelixis (EXEL) Q1 2026 Earnings Transcript - May 5th, 2026 4:51 pm
Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - May 5th, 2026 3:30 pm
Exelixis (EXEL) Tops Q1 Earnings Estimates - May 5th, 2026 3:15 pm
Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update - May 5th, 2026 2:05 pm
Assessing Exelixis (EXEL) Valuation After Mixed Share Performance And CABOMETYX Growth Narrative - May 2nd, 2026 12:17 am
Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Apr 28th, 2026 8:00 am
Pancreatic Neuroendocrine Tumors Market Research Report 2025-2035, Competitive Analysis of Key Players - Novartis, Pfizer, Exelixis, Merck, Ipsen Pharma, and Takeda Pharma - Apr 28th, 2026 2:03 am
Why Dow Jones Stock Merck Skidded 4% — And Boosted A Key Rival - Apr 21st, 2026 2:15 pm
Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026 - Apr 21st, 2026 2:05 pm
Assessing Exelixis (EXEL) Valuation After Recent Short Term Share Price Pressure - Apr 17th, 2026 3:05 pm
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist - Apr 16th, 2026 4:05 pm
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - Apr 16th, 2026 10:10 am
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - Mar 31st, 2026 6:09 am